Approval · Notice of Compliance 4241 · 1996
SERC: Notice of Compliance 4241
Issued October 23, 1996
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4241
- Date
- October 23, 1996
- Company
- Solvay Pharma Inc.Saint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Antivertigo
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SERC | 02222035 | Cancelled Post Market |
Medicinal ingredients
- BETAHISTINE HYDROCHLORIDE 4 MG per TAB